1. Introduction {#sec1}
===============

Leishmaniasis is a parasitic disease caused by an obligate intracellular parasite of genus *Leishmania,* which is transmitted to human by the bite of a female sand fly [@bib1]. The disease has wide clinical spectrums from self-limiting cutaneous to fatal visceral form which depends on both host immune response and the species of *Leishmania* parasite. The World Health Organization (WHO) emphasizes on leishmaniasis as one of the seven important infections [@bib2]. Approximately, 350 million people in 98 countries are at the risk of infection. It is estimated that 12 million people are affected with the disease and about 1.5 million new cases of cutaneous leishmaniasis (CL) are reported annually. Approximately, 90% of the CL cases occur in eight countries of Afghanistan, Saudi Arabia, Syria, Iran, Algeria, Iraq, Brazil and Peru [@bib3], [@bib4]. Pentavalent antimony is conventionally used from 1959 for leishmaniasis but it is toxic with side effects, which requires prolong injections. The efficacy of pentavalents has been decreased and the emergence of resistance limits their usage [@bib5], [@bib6]. The first line drugs in leishmaniasis including meglumine antimoniate (Glucantime), pentamidine (Pentacarinat), and sodium stibogluconate (Pentostam) are not effective orally and require prolonged injections. The second line drugs such as amphotricine B and pentamidine are very toxic [@bib5]. In the absence of an effective vaccine, there is an urgent need for new and more effective drugs to replace or supplement those in current use. Plant derivatives or plant extracts are likely to provide a valuable source of new medicinal agents. The urgent need for substituting treatments has led to a program for screening natural products in leishmaniasis. Actually, the WHO recommended the use of traditional medicine in societies with poor health services. Moreover, the data obtained from reviewing would lead to the emergence of natural products with anti-leishmanial activity and would be the way for the production of new effective synthetic compounds. It has been estimated that there are about 250,000 medicinal plant species in the world. Nevertheless, the biological activities of only about 6% of them have been evaluated. Besides, only around less than 1% of medicinal plant compounds have been assessed in clinical trials [@bib6], [@bib7].

About 35% of approved drugs belong to natural products or semi synthetic derivatives, while 30% are synthetic molecules based on natural products or pharmacophore developed from natural compounds. It is noteworthy, out of 15 antiparasitic medications that have been approved by health authorities between January 1981 and June 2006, 65% are natural products or derivatives [@bib8].

Medicinal plants are an effective source of pharmaceutical products in Iran [@bib9], [@bib10]. A critical evaluation of the clinical data due to the adverse effects has shown that herbal medicine is generally accepted better than synthetic medications. However, potentially, serious adverse events including herbal drug interactions have been described. This suggests the need to be attentive when using herbal therapies, mainly in specific situations such as throughout pregnancy and in the children age group [@bib11]. About 820 forms of herbal drugs are produced in Iran [@bib12], [@bib13]. However, in different cultures and countries, indigenous medicinal plants are used to treat parasitic diseases such as leishmaniasis. Hence, clinical trials and empirical studies have been carried out about medicinal plants in different parts of the world especially in Asian countries including Iran [@bib9], [@bib14]. Our study attempts to provide an overview on the native medicinal plants, which was investigated against *Leishmania* parasite in Iran.

2. Methods {#sec2}
==========

2.1. Search method {#sec2.1}
------------------

An exclusive search was performed through all scientific databases from April 1999 to August 2015 including five English databases (Science Direct, Scopus, Ebsco, Pub Med and Google Scholar), four Persian databases (Iran medex, Magiran, Iran doc) and the Scientific Information Database (SID). All articles which related to the medicinal plants and leishmaniasis were chosen ([Fig. 1](#fig1){ref-type="fig"}). Additionally, reference lists of all articles were reviewed for prevention of missing relevant data. The search terms were: " *Leishmania*," "plant extract," "herbal extract," "medicinal plants," "traditional medicine," and " herbal medicine" alone or in combination together. Furthermore, the synonyms of herbal medicines were considered as follow: herbal preparations, herbal medications, herbal products, herbal remedies, medicinal herbs and phytopharmaceuticals. Other relevant topics such as *Leishmania* parasite were also reviewed and included if the appropriate outcomes were retrieved. The search was performed both in English and Persian languages.Figure 1Flowchart describing the study design process.Figure 1

2.2. Paper selection {#sec2.2}
--------------------

Papers selected for inclusion were studied carefully; repetitive papers, studies out of Iran and papers with poor methodology were excluded. (See [Fig. 1](#fig1){ref-type="fig"}). The following information was extracted: the year of publication, the first author, parasite species, herbal plant, type of extract, part of plant used for extraction, concentrations, exposure time, animal models, diameter of lesions and outcomes. Two reviewers independently screened studies identified for inclusion and determined study eligibility (Kapp index showed an agreement 89% between two reviewers). Disagreements were resolved by the third opinion.

2.3. Statistical analysis {#sec2.3}
-------------------------

In this meta-analysis, the mean and 95% confidence intervals of the half-maximal inhibitory concentration (IC50) values were calculated for each individual study in order to estimate the pooled mean of herbal extract effect on *Leishmania* spp. in Iran. The results were reported using a random-effect model with 95% confidence interval (CI). Heterogeneity among studies was evaluated by the Q-Cochran test (p \< 0.1 indicate heterogeneity) and I-square statistic \[low (25%--49%), moderate (50%--74%) and high (≥75%) [@bib12]. Subgroup analysis was performed to investigate potential sources of heterogeneity [@bib14]. Publication bias was evaluated using the funnel plots and Egger test [@bib15]. Statistical software Stata 11 (Stata Corp, College Station, TX, USA) was used to data analysis.

3. Results {#sec3}
==========

Out of 7500 articles of literature searched from 1999 to 2015, 68 articles with 188 experiments (140 in vitro and 48 in vivo), met our eligibility criteria and included the current systematic review and meta-analysis. Unpublished data, duplicated papers, congresses proceeding abstracts were excluded from our systematic review and meta-analysis. Totally, data extracted comprised of 98 types of plants, their families, extraction methods, animal models IC50 and *Leishmania* species. In the in vitro studies, all of plant extracts were tested on three genera of Iranian strains of *Leishmania* spp including *L. tropica, L. major* and *L. infantom*. In the in vivo studies, most of *L. major* strains were including (MHOM/64/IR/ER75), (MRHO/IR/75/ER), (MRHO/SU/59/P), (MRHO/IR/76/ER) and also most *L. tropica* strains were (MHOM/IR/2002/Mash2) and (MHOM/TN/80/IPI1), which were maintained in Balb/c mice and human. Therefore, we attempt to summarize a list of various studies in the list of herbs and natural products with antileishmanial activity ([Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}). Briefly, most leishmanicidal agents studied from natural sources in Iran were *Artemisia species, Allium sativum, Achillea millefolium* (Yarrow), *Peganum harmala* and *Thymus vulgaris*. Heterogeneity test was conducted and Q statistic was very large (Q = 1945, df = 61, I-square = 100%, p \< 0.001), showing that there was a great variation among studies. Based on random effect model, the pooled mean of IC 50 was obtained 456.64 (95% CI: 396.15, 517.12). Begg\'s test showed that there was no publication bias among all studies (t = 1.25, p = 0.215). Subgroup meta-analysis of characters such as stem bark, preparation, family and botanical name was carried out. The results showed that IC50 was significantly different among the parts used (or stem bark) (p \< 0.001) and the "Aerial" and "Leaves or twigs" parts were most parts used. Also subgroup analysis revealed that there was a significant difference in preparing characters including: hexane, dichloromethane, hydroalcoholic, ethyl acetate with higher IC50 values and aqueous or methanolic with lower IC50 values (p \< 0.001) ([Table 3](#tbl3){ref-type="table"}). The IC50 values for *Allium* spp*, Alkanna* spp and *Artemisia* spp showed the significant difference (p \< 0.001), so that it could be with the highest value for *Allium* spp. For details on the models or mechanism-based bioassays utilized for selecting crude plant extracts, fractions and pure compounds against the *Leishmania* parasite, the original references should be consulted ([Fig. 2](#fig2){ref-type="fig"}).Figure 2Based on random effect meta-analysis (Q = 1945, df = 61, I-square = 100%, p \< 0.001) pooled mean of IC50 was obtained 456.64 (95% CI: 396.15, 517.12). Begg\'s test showed there is no evidence publishing bias among studies (t = 1.25, p = 0.215).Figure 2Table 1Included publications of survey on the efficacy and activity of herbal medicines used against leishmaniasis in vitro in Iran.Table 1Family and botanical namePreparationOrganism (strain) testedStem barkConcentrationExposure timeResultReference*Allium hirtifolium*Hydro alcoholic*L. infantum*Fruit0.01, 0.05, 0.1 and 0.2 mg/mLFor 7 daysParasite growth at all concentrations was stopped after 3 days but at concentrations of 0.2 the first day was inhibited[@bib16]*A. aucheri*Methanolic*L. major*Aerial parts150, 300, 450, 600, and 750 μg/mL24, 48, and 72 h750 μg/mL methanolic extract of *A. aucheri* was able to kill about 25% of both developmental stages of the parasite after 72 h[@bib17]*Camellia sinensis*Methanolic*L. major*Green leaves150, 300, 450, 600, and 750 μg/mL hours24, 48 and 72 hMethanolic extract of *C. sinensis* inhibited the parasite multiplication*Mimosa tenuiflora*Methanolic*L. tropica*NR20,200,1000 and 2000 μg/mL72 hConcentration of 1000 and 500 μg/mL suppressed multiplication of promastigotes but at a concentration of 100 μg/mL it accelerated growth of promastigotes.[@bib18]*Perovskia abrotanoides Karel*Methanolic*L. major (MRHO/IR/75/ER)*Root0.06, 0.12, 0.25, 0.5 and 1 mg/mL2, 4 and 6 days incubationIC50 = 926, 723 and 550 μg/mL after 2, 4 and 6 days\
Of incubation[@bib19]*P. abrotanoides Karel*Ethanolic*L. major (MRHO/IR/75/ER)*Root0.06, 0.12, 0.25 0.5 and 1 mg/mL2, 4 and 6 days incubationIC50 = 213, 652 and 343 μg/mL after 2, 4 and 6\
days of incubation,*Peganum harmala*Unknown*L. major (MRHO/SU/59/P)*Seed5000-20000 μg/mL and 62.5--500 μg/mL72 hIC50° = 1832.65 ± 89.72 μg/mL[@bib20]*Ferula szowitsiana*Unknown*L. major*Root10,100, 500 and 1000 μg/mL48 hIC50 = 4.9 μg/mL[@bib21]*Peganum harmala*Aqueous*L. major (MRHO/IR/75/ER)*Seeds20,40,100 and\
200 μg/mL24, 48 and 60 hIC50 *P. harmala* after 60 h = 0.7 μg/mL\
IC50 *A. tinctoria* after 60 h = 0.7 μg/mL\
IC50 combination of two extracts after 60 h = 0.6 μg/mL[@bib22]*Alkanna tincturia*Chloroformic*L. major (MRHO/IR/75/ER)*Stems and roots20,40,100and\
200 μg/mL24, 48 and 60 h*A. aucheri*Methanolic*L. major (MRHO/IR/76/ER)*Aerial parts31.25, 62.5, 125, 250, 500 and 5000 μg/mLNRIC50 = 7.5 μg/mL[@bib23]*F. asafoetid*Methanolic*L. major (MRHO/IR/76/ER)*Gum31.25, 62.5, 125, 250, 500 and 5000 μg/mLNRIC50 = 5.9 μg/mL*Gossypium hirsutum*Methanolic*L. major (MRHO/IR/76/ER)*Boll31.25, 62.5, 125, 250, 500 and 5000 μg/mLNRIC50 = 3.6 μg/mL (better effect)*Echinacea purpurea*Ethanolic*L. major (MRHO/IR/75/ER)*Root0.5, 2.5, 50 and 125 mg/mL8, 16, 24, 48 and 72 hLD50 for the promastigotes were determined as 22,300,\
16,700, 36,600, 19,800 and 1230 μg/mL at 8, 16, 24, 48 and 72 h respectively.\
125,000 and 50,000 μg/mL concentrations of this extract were able to kill 100% of the parasite after 48 h[@bib24]*Calendula officinalis*Aqueous*L. major (MRHO/IR/75/ER)*Flowers500, 250, 125 and 62.5 μg/ml24,48,72 hIC50 was calculated for ethanolic & watery *C. officinalis*; 170 μg/mL, 215μg/mL after 24 h respectively.\
The extract at concentration of 500 μg/ml was found to kill all the parasites.[@bib25]*C. officinalis*Ethanolic*L. major (MRHO/IR/75/ER)*Flowers500, 250, 125 and 62.5 μg/ml24,48,72 h*A. sativum*Aqueous*L. major (MRHO/IR/75/ER)*Small pieces0, 10, 20, 40, 60, 80, 100 μg/mL72 hIC50 = 37 μg/mL.\
Cytotoxic effect in *L. major* with almost 100% death at a concentration of 93 μg/mL[@bib26]*Satureja khuzestanica*Ethanolic*L. major (MRHO/IR/75/ER)*Aerial parts0.07--19.9 mg/mlafter 24 hEthanolic extract\
IC100 = 2400 μg/mL\
IC50 = 300 μg/mL.[@bib27]*S. khuzestanica*Methanolic*L. major (MRHO/IR/75/ER)*Aerial parts0.07--19.9 mg/mLafter 24 hMethanoic extract\
IC100 = 4800 μg/mL\
IC50 = 600 μg/mL.*A.*\
*sativum*Aqueous*L. major (MRHO/IR/75/ER)*Bulbs(9.25, 18.5, 37, 74, 148 mg/mL18, 24 and 48 hIC50 = 37,000 μg/mL.[@bib28]*Arnebia euchroma*Alcoholic*L. major (MRHO/IR/75/ER)*Root0.78, 1.5, 3.2, 6.5 and 12.5 mg/mL0, 24, 48, 72 and 96 hThe results showed a significant decrease in the number of *Leishmania* parasites over time was due to the effect of the extract.[@bib29]*Achillea millefolium*Alcoholic*L. major (MRHO/IR/75/ER)*Root0.78, 1.5, 3.2, 6.5 and 12.5 mg/mL0, 24, 48, 72 and 96 h*Green tea*Ethanolic*L. major (MRHO/IR/75/ER)*Leaves3, 6, 12, 24, 48 and 96 mg/mL24,48,72 hThe effect of different concentrations of the plant extract on *Leishmania* revealed that all the concentrations of this extract can reduce the number of Leishmania parasites[@bib30]*A. millefolium*Alcoholic*L. major (MRHO/IR/75/ER)*Leaves3, 6, 12, 24, 48 and 96 mg/mL0,24,48,72 h*Wormwood*Alcoholic*L. major (MRHO/IR/75/ER)*Flowers25 mg/mL0,24,48,72 hThe effect of different concentrations of the plant extract on *Leishmania* revealed that all the concentrations of This extract can reduce the number of *Leishmania* parasites.\
Plant extracts increased immobility parasite that this lack of mobility is directly related to time.[@bib31]*Walnut leaves*Alcoholic*L. major (MRHO/IR/75/ER)*Leaves25 mg/mL0,24,48,72 h*Verbascum thapsus*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 = 452 ± 4.47 μg/mL[@bib32]*Caparis spinosa*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 = 375 ± 2.96 μg/mL*Amarusthus rutroflena*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 = 275 ± 7.45 μg/mL*Sesamum indium*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 = 245 ± 3.78 μg/mL*A. absintin*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 = 280 ± 5.96 μg/mL*Tribulus terresttis*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 ≥ 625 μg/mL*Ficus bengalensis*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 = 200 ± 23.14 μg/mL*Prosropis juliflorea*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 = 312 ± 14.625 μg/mL*A. dracunculus*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 ≥ 625 μg/mL*Paliurus spina Christi*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 ≥ 625 μg/mL,*Rhamnus persica boiss*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 = 75 ± 13.44 μg/mL*Caesalpinia gilliesii*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 = 9.76 ± 1.27 μg/mL*Acacia faresiana*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 = 625 ± 12.75 μg/mL*Satureia hortensis*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 = 15.625 ± 3.76 μg/mL*Carum copticum heirm*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 = 15.625 ± 3.76 μg/mL*Thymus migricus*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50 = 31.25 ± 15.44 μg/mL*A. vulgari*Hydro alcoholic*L. major (MRHO/IR/76/ER)*Leaves or twigs5 to 500 μg/mLAfter 28--30 hIC50= \>625 μg/mL*Stachys lavandulifolia Vahl*Hydro alcoholic*L. major (MRHO/75/IR)*Aerial part50, 100, 250, 500 and 1000 μg/mLNRWith increasing concentrations of *S. lavandulifolia* and leaves *M. germanica* extract reduced the number promastigotes. Efficacy of the two extract were not significant difference and almost have same effect on the average number of *Leishmania* promastigotes[@bib33]*Mespilus germanica*Hydro alcoholic*L. major (MRHO/75/IR)*Leaves50, 100, 250, 500 and 1000 μg/mLNR*Calotropis gigantea*Methanolic*L. major*Aerial parts0.12, 0.25, 0.50 and 1.0 mg/mL24, 48, 72 hIC50 = 96.3 μg/mL[@bib34]*C. gigantea*Hexane*L. major*Aerial parts0.12, 0.25, 0.50 and 1.0 mg/mL24, 48, 72 hIC50 = 92.5 μg/mLC. giganteaAqueous*L. major*Aerial parts0.12, 0.25, 0.50 and 1.0 mg/mL24, 48, 72 hIC50 = 11.3 μg/mLC. giganteaButanolic*L. major*Aerial parts0.12, 0.25, 0.50 and 1.0 mg/mL24, 48, 72 hIC50 = 58.7 μg/mLArtimisininEthanolic*L. major* (*MR HO/HR/75/ER)*Leaves10, 25, 50 and 100 μg/mLincubated for 72 hIC50 = 68.16 μg/mL[@bib35]*Artemisia annua*Ethanolic*L. major*Aerial partsNRNRIC50 = 400 ± 0.8 μg/mL[@bib36]*A. annua*Ethyl acetate*L. major*Aerial partsNRIC50 = 425 ± 1.5 μg/mL*A. annua*Dichloromethane*L. major*Aerial partsNRIC50 = 850 ± 0.9 μg/mL*A. annua*Hexane*L. major*Aerial partsNRIC50 = 1900 ± 2.4 μg/mL*A. biennis*Ethanolic*L. major*Aerial partsNRIC50 = 100 ± 0.9 μg/mL*A. biennis*Ethyl acetate*L. major*Aerial partsNRIC50 = 425 ± 0.5 μg/mL*A. biennis*Dichloromethane*L. major*Aerial partsNRIC50 = 525 ± 1.1 μg/mL*A. biennis*Hexane*L. major*Aerial partsNRIC50 = 1050 ± 2.0 μg/mL*A. ciniformis*Ethanolic*L. major*Aerial partsNRIC50 = 25 ± 0.4 μg/mL\
The ethanol extracts of *A. ciniformis* has one of the most potent leishmanicidal activity.*A. ciniformis*Ethyl acetate*L. major*Aerial partsNRIC50 = 340 ± 1.2 μg/mL*A. ciniformis*Dichloromethane*L. major*Aerial partsNRIC50 = 450 ± 1.0 μg/mL*A ciniformis*Hexane*L. major*Aerial partsNRIC50 = 790 ± 1.7 μg/mL*A. sieberi*Ethanolic*L. major*Aerial partsNRIC50 = 150 ± 1.0 μg/mL*A. sieberi*Ethyl acetate*L. major*Aerial partsNRIC50 = 265 ± 0.7 μg/mL*A. sieberi*Dichloromethane*L. major*Aerial partsNRIC50 = 465 ± 0.8 μg/mL*A. sieberi*Hexane*L. major*Aerial partsNRIC50 = 850 ± 1.5 μg/mL*A. kulbadica*Ethanolic*L. major*Aerial partsNRIC50 = 25 ± 0.5 μg/mL\
The ethanol extracts of *A*. *kulbadica has one of* the most potent leishmanicidal activity.*A. kulbadica*Ethyl acetate*L. major*Aerial partsNRIC50 = 275 ± 1.4 μg/mL*A. kulbadica*Dichloromethane*L. major*Aerial partsNRIC50 = 440 ± 0.7 μg/mL*A. kulbadica*Hexane*L. major*Aerial partsNRIC50 = 885 ± 1.8 μg/mL*A. santolina*Ethanolic*L. major*Aerial partsNRIC50 = 80 ± 0.8 μg/mL\
The ethanol extracts of *A. santolina* has one of the most potent leishmanicidal activity.*A. santolina*Ethyl acetate*L. major*Aerial partsNRIC50 = 375 ± 1.1 μg/mL*A. santolina*Dichloromethane*L. major*Aerial partsNRIC50 = 675 ± 1.4 μg/mL*A. santolina*Hexane*L. major*Aerial partsNRIC50 = 850 ± 1.4 μg/mL*A. turanica*Ethanolic*L. major*Aerial partsNRIC50 = 200 ± 1.3 μg/mL*A. turanica*Ethyl acetate*L. major*Aerial partsNRIC50 = 675 ± 2.1 μg/mL*A. turanica*Dichloromethane*L. major*Aerial partsNRIC50 = 425 ± 0.9 μg/mL*A turanica*Hexane*L. major*Aerial partsNRIC50 = 1120 ± 2.5 μg/mL*A. absinthium.*Ethanolic*L. major*Aerial partsNRIC50 = 500 ± 0.6 μg/mL*A. absinthium.*Ethyl acetate*L. major*Aerial partsNRIC50 = 425 ± 1.3 μg/mL*A absinthium*Dichloromethane*L. major*Aerial partsNRIC50 = 600 ± 0.8 μg/mL*A. absinthium.*Hexane*L. major*Aerial partsNRIC50 = 1050 ± 2.5 μg/mL*A. fragrans*Ethanolic*L. major*Aerial partsNRIC50 = 1000 ± 2.0 μg/mL*A. fragrans*Ethyl acetate*L. major*Aerial partsNRIC50 = 1375 ± 2.2 μg/mL*A. fragrans*Dichloromethane*L. major*Aerial partsNRIC50 = 475 ± 1.0 μg/mL*A. fragrans*Hexane*L. major*Aerial partsNRIC50 = 1150 ± 2.2 μg/mL*A. khorassanica*Ethanolic*L. major*Aerial partsNRIC50 = 400 ± 1.1 μg/mL*A. khorassanica*Ethyl acetate*L. major*Aerial partsNRIC50 = 435 ± 0.7 μg/mL*A. khorassanica*Dichloromethane*L. major*Aerial partsNRIC50 = 500 ± 1.2 μg/mL*A. khorassanica*Hexane*L. major*Aerial partsNRIC50 = 790 ± 1.5 μg/mL*A. kopedaghensis*Ethanolic*L. major*Aerial partsNRIC50 = 50 ± 0.7 μg/mL*A. kopedaghensis*Ethyl acetate*L. major*Aerial partsNRIC50 = 255 ± 0.8 μg/mL*A. kopedaghensis*Dichloromethane*L. major*Aerial partsNRIC50 = 445 ± 0.5 μg/mL*A. kopedaghensis*Hexane*L. major*Aerial partsNRIC50 = 925 ± 1.6 μg/mL*A. seiberi*Aqueous*L. major (MRHO/IR/75/ER)*Aerial parts and roots5, 10, 25, 50 and 100 μg/mL24,48 and 72 hIC50 = 25 μg/mL\
*A. sieberi* has a higher growth inhibitory effect on promastigotes but The cytotoxic effect of seven concentrations of *Artemisia sieberi* on uninfected splenic macrophages of Balb/c mice has h very low cytotoxic effect on uninfected and healthy macrophages[@bib37]*A. sieberi*Aqueous*L. major (MRHO/IR/75/ER)*Aerial parts & root1, 5, 10,20 and 25%24, 48 and 72 hThat promastigotes in RPMI culture were killed completely under concentrations of 20% and 25% of *Artemisia* in the first day.\
Concentrations of 20% of *Artemisia* in the second day led to the complete elimination of amastigote of *L. major* in macrophages[@bib38]*Scrophularia striata*Aqueous*L. major (MRHO/IR/75/ER)*Aerial parts & root1, 5, 10,20 and 25%24, 48 and 72 hThe parasites were killed by *Scrophularia* at the concentration of 25% within three days.\
Concentrations of 25% of *Scrophularia* in the third day led to the complete elimination of amastigote of *L. major* in macrophages*Indium curcumin*Unknown*L. major (MRHO/IR/75/ER)*Turmeric plant extractsNRNRIC50 = 26 μg/mL\
IC50 standard (Amphotericine B) = 20 μg/mL\
*I. curcumin* with IC50 values of 26 μg/mL was more\
effective than other three test agents against *Leishmania*.[@bib39]*Diacethyle curcumin*Unknown*L. major (MRHO/IR/75/ER)*Turmeric plant extractsNRNRIC50 = 52 μg/mL*Gallium*\
*curcumin*Unknown*L. major (MRHO/IR/75/ER)*Turmeric plant extractsNRNRIC50 = 32 μg/mL*G.*\
*curcumin*Unknown*L. major (MRHO/IR/75/ER)*Turmeric plant extractsNRNRIC50 = 38 μg/mL*Alkanna frigida*Ethyl acetate*L. major*Root limb62.5, 125, 250 and 500 μg/mL.24, 48, and 72 hThe inhibitory effects = 46%\
IC50 = 106 μg/mL[@bib40]*A. frigida*Ethanolic*L. major*Root limb62.5, 125, 250 and 500 μg/mL24, 48, and 72 hThe inhibitory effects = 45%\
IC50 = 86 μg/mL*A.frigida*Chloroformic*L. major*Root limb62.5, 125, 250 and 500 μg/mL24, 48, and 72 hThe inhibitory effects = 13%\
IC50 value after 48 and 72 h = 330 and 68 μg/mL*A. frigida*Hexane*L. major*Root limb62.5, 125, 250 and 500 μg/mL24, 48, and 72 hThe inhibitory effects = 15%\
IC50 value= (384 μg/mL for 48 h) and (98 μg/mL 72 h).*Nerium oleander, ricinus communis, capsicum, almond powder*Unknown*L. major*Leaves and stems1/10, 1/100, 1/1000 and 1/10,000For 7 weeksIn terms of quantity, the number of promastigotes of *Leishmania* in the face of the herbal combination reduced compared with the control group[@bib41]*Artemether*Unknown*L. infantum (MHOM/TN/80/IPI1)*Ointment and injection0, 10, 25, 50,\
and 100 μg/mL.72 hIC 50 = 25 μg/mL after 24 h[@bib42]*aloe-emodin*Unknown*L. major*Powder40, 80, 120 and 160 μg/mL24, 48 and 72 hIC50 = 52.79 μg/mL.[@bib43]*Scrophularia striata*Aqueous*L. major*Aerial parts and root1, 5, 10,20 and 25%72 hIn treatment of promastigotes of *L. major* with *S. striata* extract at the concentration of 25%, the parasites were killed at the day three[@bib44]*Nigella sativa*Essential oil*L. major (MRHO/IR/75/ER)*Aerial parts0.1, 0.2, 0.4, 0.8, 1.2, 1.6 and 2%24, 48 and 72 hThere was a significant difference in reducing parasites on groups receiving Satureia hortensis and *N. sativa* with Glucantime[@bib45]*S. hortensis*Essential oil*L. major (MRHO/IR/75/ER)*Aerial parts0.1, 0.2, 0.4, 0.8, 1.2, 1.6, and 2%24, 48 and 72 h*A. cepa*Aqueous*L. major*Root0.312, 2.5 and 5 mg/mL24 and 48 hThe viability of the *L. major* promastigotes in the concentration of 312 μg/mL aqueous onion extracts was 80% and in the same concentration, 20% of the *L. major* promastigotes were unmovable. At the concentration of 2500 μg/mL aqueous *A. cepa* extracts, 70% of the *L. major* promastigotes were unmovable and the viability of promastigotes was 30%. Moreover, in the concentration of 5000 μg/mL of aqueous *A. cepa* extracts, 100% of the *L. major* promastigotes were unmovable and the viability of parasites in this concen-tration was 0%.\
IC50 = 1250 μg/mL IC100 = 5000 μg/mL[@bib46]*Ixora brachiata*Ethanolic*L. major*Root0.312, 2.5 and 5 mg/mL24 and 48 hIn addition, at the concentra-tion of 2500 μg/mL ethanolic and methanolic extracts of *I. brachiata* root, 100% of the *L. major* promastigotes were unmovable and the viability of the *L. major* promasti-gotes in the same concentration was 0%.in the concentration of 5000 μg/mL of aqueous *A. cepa* extracts, 100% of the *L. major* promastigotes were unmovable and the viability of parasites in this concen-tration was 0%.\
Ethanolic extract of *Ixora brachiata* root IC50 = 78 μg/mL IC100 = 2500 μg/mL\
Aqueous A. *cepa* = IC50 = 1250 μg/mL IC100 = 5000 μg/mL*Hyssopus officinalis*Alcoholic*L. major (MRHO/IR/75/ER)*Leaves0, 05, 0.1, 0.2, 0.4 and 1 μg/mL24, 48 and 72 hThat extract was effective[@bib47]*Tussilago farfara*Alcoholic*L. major (MRHO/IR/75/ER)*Leaves0, 05, 0.1, 0.2, 0.4 and 1 μg/mL24, 48 and 72 hThat extract was effective*Carum copticum*Alcoholic*L. major (MRHO/IR/75/ER)*Seed0, 05, 0.1, 0.2, 0.4 and 1 μg/mL24, 48 and 72 hThat extract was effective*B. vulgaris*Methanolic*L. tropica (MHOM/IR-/2002/Mash2)*Aerial partsBetween 5 and 100 μg/mL and 1--10 μg/mLfor 48 h at 37 °CInhibitory effects against promastigote forms\
IC50 = 16.1 μg/mL\
Inhibitory effects against amastigote forms\
IC50 = 39.4 μg/mL[@bib48]*B. vulgaris*Aqueous*L. tropica (MHOM/IR-/2002/Mash2)*Aerial partsBetween 5 and 100 μg/mL and 1--10 μg/mLfor 48 h at 37 °CInhibitory effects against promastigote forms\
IC50 = 26.6 μg/mL\
Inhibitory effects against amastigote forms\
IC50 = 59.2 μg/mL*B. vulgaris*Methanolic*L. infantum (MCAN/IR/07/Moheb-gh)*Aerial partsBetween 5 and 100 μg/mL and 1--10 μg/mLfor 48 h at 37 °CInhibitory effects against promastigote forms\
IC50 = 13.2 μg/mL\
Inhibitory effects against amastigote forms\
IC50 = 52.8 μg μg/mL*B. vulgaris*Aqueous*L. infantum (MCAN/IR/07/Moheb-gh)*Aerial partsBetween 5 and 100 μg/mL and 1--10 μg/mLfor 48 h at 37 °CInhibitory effects against promastigote forms\
IC50 = 21.6 μg/mL\
Inhibitory effects against amastigote forms\
IC50 = 3.9 μg/mL*Vinca major*Chloroformic*L. major*Leaves and stems0,150, 300, 450, 600, 750 μg/mL0,24,48,72 and 96 hAt a concentration of 750 mg/mL after 96 h led to destroy all parasites[@bib49]*A. sativum*Methanolic*L. tropica (MHOM/IR/2002/Mash2)*Bulbs3.125, 6.25, 12.5, 25, 50, and 100 μg/mL72 h incubationThe IC50 values methanolic extracts of *garlic*\
IC50 = 12.3 μg/mL\
The IC50 values aqueous extracts of *garlic*\
IC50 = 19.2 l μg/mL\
The IC50 values methanolic extracts of *garlic*\
CC50 = 291.4 μg/mL\
The IC50 values aqueous extracts of *garlic*\
CC50 = 348.2 μg/mL[@bib50]\
[@bib51]*A. sativum*Aqueous*L. tropica (MHOM/IR/2002/Mash2)*Bulbs3.125, 6.25, 12.5, 25, 50, and 100 μg/mL72 h incubation*Myrtus communis*Essential oil*L. tropica (MHOM/IR/2002/Mash2)(pro&ama)*Leaves3.125, 6.25, 12.5, 25, 50, and 100 μg/mL72 h incubationThe IC50 values for essential oil and methanolic extract was 8.4 and 28.9 μg/mL against promastigotes, respectively.\
These values were 11.6 and 40.8 μg/mL against amastigote forms,*M.communis*Methanolic*L. tropica (MHOM/IR/2002/Mash2)*Leaves3.125, 6.25, 12.5, 25, 50, and 100 μg/mL72 h incubation*N. sativa*Essential oil*L. tropica*Aerial parts0--200 μg/mL72 h incubationInhibitory effects against promastigote forms\
IC50 = 9.3 μg/mL\
Inhibitory effects against amastigote forms\
IC50 = 21.4 μg/mL[@bib52]*N. sativa*MethanolicL. tropicaAerial parts0--200 μg/mL72 h incubationInhibitory effects against promastigote forms\
IC50 = 14.8 μg/mL\
Inhibitory effects against amastigote forms\
IC50 = 30.8 μg/mL*N. sativa*Essential oil*L. infantum*Aerial parts0--200 μg/mL72 h incubationInhibitory effects against promastigote forms\
IC50 = 11.7 μg/mL\
Inhibitory effects against amastigote forms\
IC50 = 26.3 μg μg/mL*N. sativa*Methanolic*L. infantum*Aerial parts0--200 μg/mL72 h incubationInhibitory effects against promastigote forms\
IC50 = 15.7 μg/mL\
Inhibitory effects against amastigote forms\
IC50 = 34.6 μg/mL*Kelussia odoratissim*Essential oil*L. major (MRHO/IR/75/ER)*Aerial parts7.5, 15, 25, 35.25 and 50 μl24, 48 and 72 hHigher concentrations (35.25 and 50 μl/mL had a stronger effect on promastigotes, causing total mortality.[@bib53]*Cordia myxa*Mucilage*L. major*Fruits0.6,1.2,2.4,4.8,9.6,19.5,39,78 and 176 mg/mLfor 72 hIC50 = 26,000 μg/mL[@bib54]*C. myxa*Mucilage*L. infantum*Fruits0.6,1.2,2.4,4.8,9.6,19.5,39,78 and 176 mg/mLfor 72 hIC50 = 35,000 μg/mL*Caparis spinosa*Methanolic*L. major (MRHO/IR/75/ER)*Root0.1, 0.3, 0.5, 0.7 and 0.9 mg/mL24, 48 and 72 hIt was determined that anti-protozoal activity of *Caparis* extract (900 μg/mL) was able to kill 97.8% of promastigotes after 72 h[@bib55]*Pistacia khinjuk*Alcoholic*L. tropica (MHOM/IR/2002/Mash2) & L. major (MRHO/IR/75/ER)*Fruits0--100 μ/mLfor 48 hPromastigote:\
IC50 = 58.6 ± 3.15 μg/mL\
Amastigote:\
IC50 = 37.3 ± 2.51 μg/mL[@bib56]*Eucalyptus camaldulensis*Aqueous*L. major (MRHO/SU/59/P)*Leaves25, 50, 312.5, 625 and 1,25072 hIC50 = 1108.6 ± 51.9 μ/mL ,[@bib57]*E. camaldulensis*Methanolic*L. major (MRHO/SU/59/P)*Leaves25, 50, 312.5, 625 and 1,25072 hIC50 = 586.2 ± 47.6 μ/mL\
Methanolic extract was more effective than aqueous extract.\
This extract were less effective as compared to the control drμg*A. absinthium,*Methanolic*L. major (MROH/IR/75/IR)*Leaves31.25--1000 μg/mL.0-30 daysIC50 = 159.45 μ/mL\
Toxicity for macrophage cell line=10%[@bib58]*Vitex agnuscastus*Methanolic*L. major (MROH/IR/75/IR)*Leaves31.25 to 1000 μg/mL.0-30 daysIC50 = 234.15 μ/mL\
Toxicity for macrophage cell line = 8%*Phytolaca americana*Methanolic*L. major (MROH/IR/75/IR)*Fruits31.25 to 1000 μg/mL.0-30 daysIC50 = 171.1 μ/mL\
Toxicity for macrophage cell line = 12%[^1][^2][^3][^4][^5]Table 2Included publications of survey on the efficacy and activity of herbal medicines used against leishmaniasis in vivo in Iran.Table 2Family and botanical namePreparationOrganism testedStem barkAnimals kindConcentrationResultReference*Z-HE*[a](#tbl2fna){ref-type="table-fn"}Crude extract*L. major*-HumanTopicalIn the group treated with Z-HE (group A), complete cure was observed in 74.4% ([Figure 1](#fig1){ref-type="fig"}, [Figure 2](#fig2){ref-type="fig"}), partial cure in 11.6%, and failure in 14.0%. In the group treated with meglumine antimoniate (Glucantime) (group B), complete cure was observed in 24.1%, partial cure in 14.1%, and failure in 58.8%[@bib59]*A. sativum*Aqueous*L. major*BulbsMice (Balb/c)Mices were subjected to 300,000 promastigotes.\
lesion was\
measured on days 1, 10, 20, 30 and 45The diameter of lesion was reduced by aqueous extract of *garlic* within 30 days of treatment. However, the maximum reduction was induced when mice were subjected to vitamin A for 10 days before the administration of the aqueous extract for 30 days. A significant correlation between healing and the amount of NO release was also found.[@bib60]*Berberis vulgaris*Alcoholic*L. major*Leaves, stems and rootsMice (Balb/c)2.5, 4.0, 5.5 and 7.0%The results showed that after 2 weeks, a statistically significant decrease of ulcer size of treated mice observed, while in the control group the lesion growth continued. The examinations showed that using higher concentration of the extract caused more decrease in surface area of CL lesions on day 15 and negative direct smear on day 20. Alcoholic extract of *B.vulgaris* root was more effective than leaves and stem extract.[@bib61]*Eucalyptus globulus*Essence*L.major (MRHO/IR/76/ER)*NRMice (Balb/c)Essence 10%The essences reduced the diameter of lesions or caused small lesions to disappear completely.[@bib62]*Myrtus communis*Essence*L. major (MRHO/IR/76/ER)*NRMice (Balb/c)Essence 10%, 20%No change was noticed in the size of the lesions or the number of parasites.*Ferula gumosa*Essence*L. major (MRHO/IR/76/ER)*NRMice (Balb/c)Essence 10%, 20%No change was noticed in the size of the lesions or the number of parasites.*A. herbaalba*Essence*L. major (MRHO/IR/76/ER)*NRMice (Balb/c)Essence 10%, 20%No change was noticed in the size of the lesions or the number of parasites.*A. sativum*Tincture*L. major (MRHO/IR/76/ER)*NRMice (Balb/c)Tentor 50&100%No change was noticed in the size of the lesions or the number of parasites.*Urtica dioica*Crude extract*L. major (MRHO/IR/76/ER)*NRMice (Balb/c)Pure extractNo change was noticed in the size of the lesions or the number of parasites.*A. dracunculus*Essence*L. major (MRHO/IR/76/ER)*NRMice (Balb/c)Essence 10%The essences of *A. dracunculus* reduced the diameter of lesions or caused small lesions to disappear completely.*Cassia Fistula*Concentrated boiled*L. major*FruitsHuman--Mean healing time was 4.6 ± 3.7 weeks[@bib63]*C. Fistula*Hydro alcoholic*L. major*FruitsHuman--Mean healing time was 4.9 ± 3.8 weeks. There was no significant difference between the efficacy of concentrated boiled extract and that of the hydro alcoholic extract of the *Cassia fistulaBerberis vulgaris*Alcoholic*L. major*Stem skinMice (Balb/c)20,40,80% for 30 daysWith the 20% preparation: by the end of the treatment period, the mean diameter of the lesions had decreased, with complete healing in 5 mice (27.7%), (p \< 0.001). by the time of the decrease in diameter, the mean weight of the animals had increased and the number of parasites in the lesions had declined (80%). Total elimination of the parasites was observed in 12 animals (p \< 0.001).\
At a concentration of 40%: mean ulcer diameter decreased, with complete healing in 2 mice (11.1%, p \< 0.001). By the time of the decrease in diameter, the mean weight of the mice had increased (p \< 0.05). The mean number of parasites in lesions decreased (64.3%), with total elimination in 9 animals (p\< 0.05).[@bib64]*Thymus vulgaris*Hydro alcoholic*L. major (MRHO/IR/75/ER)*NRMice (Balb/c)NRMean of ulcer size reduction = 36.09% that *T. vulgaris*, hydro alcoholic extracts were significantly more effective in reduction of ulcer size as compared with Glucantim[@bib65]*Achillea millefolium*Hydro alcoholic*L. major (MRHO/IR/75/ER)*NRMice (Balb/c)NRMean of ulcer size reduction = 43.29% that *A. millefolium* hydro alcoholic extracts were significantly more effective in reduction of ulcer size as compared with Glucantim*propolis*Hydro alcoholic*L. major (MRHO/IR/75/ER)*NRMice (Balb/c)NRMean of ulcer size reduction = 43.77% that *propolis* hydro alcoholic extracts were significantly more effective in reduction of ulcer size as compared with Glucantim*Rubia Tinctorium*Dry extract*L.major (MRHO/IR/76/ER)*RootsMice (Balb/c)40, 60 and 80%The mean weight of the mice that received 40, 60 and 80% concentrations of *R. tinctorum* extracts showed a statistically significant difference compared to the control group the mean of lesion size of the mice extracts concentrations showed no statistically significant difference compared to the control[@bib66]*A.sieberi*Hydro alcoholic*L. major (MHOM/64/IR/ER75)*NRMice (Balb/c)1,3,5% after 30 daysAt the end of the 30 day treatment period with concentrations of *Artemisia*, any of the mice treated with complete remission were observed. And microscopic examination of samples taken from the animals tested were positive.[@bib67]*Thyme*Hydro alcoholic*L. major (MRHO/IR/75/ER)*NRMice (Balb/c)NRObserved significant difference between mean of lesion diameter before and after treatment in control, *Yarrow* and *Thyme* groups Paired *t*-test showed no significant difference between mean of lesion diameter after treatment between treatment and Glucantime groups[@bib68]*Thyme*Hydro alcoholic*L. major (MRHO/IR/75/ER)*NRMice (Balb/c)NR*A. millefolium*Hydro alcoholic*L. major (MHOM/64/IR/ER75)*NRMice (Balb/c)NRUlcer dimeter Before treatment = 4/35 ± 0/5 mm\
Ulcer dimeter after treatment = 3/4 ± 0/67 mm\
The mean ulcer size in the group receiving *thyme* has been good impact on preventing The process of development of wound[@bib69]*T. vulgaris*Hydro alcoholic*L. major (MHOM/64/IR/ER75)*NRMice (Balb/c)NRUlcer dimeter Before treatment = 5/39 ± 0/41 mm\
Ulcer dimeter after treatment = 4 ± 0/34 mm\
The mean ulcer size in the group receiving *yarrow* has been good Impact on preventing The process of development of wound*Henna*Hydro alcoholic*L. major (MHOM/64/IR/ER75)*NRMice (Balb/c)NRUlcer dimeter Before treatment = 5.77 ± 0/30 mm\
Ulcer dimeter after treatment = 7/11 ± 0/56 mm\
Were did not showen statistical significant difference between mean diameter of lesions after treatment with the treated group with Plant extracts and treated with Glucantime*A. sativum*Hydro alcoholic*L. major (MHOM/64/IR/ER75)*NRMice (Balb/c)NRUlcer dimeter Before treatment = 5.18 ± 0/47 mm\
Ulcer dimeter after treatment = 7/06 ± 1/09 mm\
Were did not showen statistical significant difference between mean diameter of lesions after treatment with the treated group with Plant extracts and treated with Glucantime*Pistacia Atlantica*Unknown*L. major (MHROM/IR/75/ER)*Gum obtioned of trunk and branchesMice (Balb/c)0,4,8 weekGum daily for 28 days decreased skin lesion size in the mice infected with *L.major* compared with that in the control. Treatment Balb/c mice with gum obtained *P. atlantica* var. *kurdica* and Glucantime causes decrease number of parasitologically positive mice[@bib70]*E. camaldulensis*Methanolic*L. major (MRHO/IR/75/ER)*NRMice (Balb/c)NRAmastigote number into the lesions, were significantly decreased, nanogold solutions were also decreased mortality rate in the mice[@bib71]*Satureja khuzestanica*Essential oil*L. major MRHO/IR/75/ER*Aerial partsMice (Balb/c)0.01, 0.001, 0.0001% for 7 weekLesions\' size in SKEO treated groups was restrained but not significantly different from the control group the mortality rate in treated groups was clearly less than the control.[@bib71]*A. sativum*Aqueous*L. major*BulbsMice (Balb/c & 57BL/6 and Suri)Promastigote injection and evaluated For 8 weekThe results showed that R10 had good therapeutic efficacy in treatment of lesions in mice (P \< 0.05) that this efficacy was significant in sixth, seventh and eighth weeks after the treatment[@bib72]*Echinacea purpurea*Hydro alcoholic*L. major*Aerial partsMice (Balb/c)The mean of lesion size in each group of mice were compared and analyzed. No significant differences in the lesions size were found between the three mice groups. Therefore, *E. purpurea* extract was not effective against *L. major* based on the findings of this study.[@bib74]*Mespilus germanica*Ethanolic*L. major*LeavesMice (Balb/c)40, 60 and 80%Extract of *M. germanica* has the highest effectiveness in concentration of 40%, causing greater reductions in both ulcer diameter and the number of parasites in the lesions compared with other prepared concentrations[@bib75]*A. aucheri Boiss*Methanolic*L. major MRHO/IR/75/ER(IR/75)*NRMice (Balb/c)0.09, 0.36, 1.44, 6, 28 mg/kg for 30 daysThe results indicated that herbal extract was able to affect on lesion size, its performance and to prevent visceralization of the parasite. This is the first report indicating visceralization caused by the cutaneous form of *L. major* in the Balb/c mice[@bib76]*N. oleander, r. communis, capsicum, almond powder*Unknown*L. major*Stem and seedMice (Balb/c)1/10,1/100,1/1000,1/10,000This skin lesion at the base of the tail of mice under investigation also indicate a significant effect on the composition of the herbal form wound and skin nodule at the base of the tail of mice treated with the control group.[@bib41]*Artemether*Unknown*L. infantum ( MHOM/TN/80/IPI1)*Ointment and injectionMice (Balb/c)NRIn vivo experiments indicated that oral artemether treatment of mice, during 3 days and every 6 h (0.625 mg/kg) was more significant than parenteral (0.625 mg/kg IP) treatment[@bib42]*artemether*Unknown*L. major*Ointment and injectionMice (Balb/c)NRMean diameter of lesion in the infected group treated with ointment of *artemether* decreased from 1.294 to 0.214 cm mean diameter of lesion in the infected group treated with *artemether* injection decreased from 0.913 to 0.256 cm[@bib77]*Echium amoenum*Aqueous*L. major (MRHO/75/IR)*FlowerMice (Balb/c)0.1, 0.25, 0,50, 1, 2, 4 and 5 mg/mLIncreased the level of IFN-γ and lowered the parasite burden in the proximal lymph nodes and prevented the necrosis of the footpad as compared with the untreated infected mice.[@bib78]*E. amoenum*Alcoholic*L. major (MRHO/75/IR)*FlowerMice (Balb/c)0.1, 0.25, 0,50, 1, 2, 4 and 5 mg/mLSeidlitzia rosmarinusHydro alcoholic*L. major (MRHO/75/IR)*leavesMice (Balb/c)5, 10 and 5 15%Significant increase in the lesion size of treated mice compared with reference group except for treated group by 15% extract[@bib79]*Peganum harmala*Aqueous*L. major (MRHO/IR/75/ER)*Ground seedMice (Balb/c)NRIn the aqueous extract group only 10% of mice healed.[@bib80]*P. harmala*Ethanolic*L. major (MRHO/IR/75/ER)*Ground seedMice (Balb/c)NRIn the ethanolic extract group only 40% of mice healed. Results showed that ethanol extract of *P. harmala* had good therapeutic efficacy in treatment of lesions in mice*V. major*Cloroformic*L. major*Leaves and stemsMice (Balb/c)NRInjection was very effective By the prevention of ulcers caused by Leishmania major in Balb/c mice compared to untreated control[@bib49]*S. iastriata*Aqueous*L. major*Aerial parts& rootMice (Balb/c)1, 5, 10,20, 25% for 3 daysExtract concentration (25%) at the concentration at the first day, the extract led to a decrease in the parasite rate to 36 amastigotes. For all of the concentrations (10%, 20%, 25%) we observed completely elimination of amastigotes on the third day.[@bib44]*Hedera helix*Alcoholic*L. major (MHOM/64/IR/ER75)*LeavesMice (Balb/c)20% and 70% for 30 days.Study showed that the main lesion size did not decrease significantly, or the small lesions did not completely disappear after treatment by *H. helix* alcoholic extract. Amastigotes counts (mean ± SD) of the skin lesions decreased in control A and 20% concentration groups, but in negative control and 70% concentration groups the number of parasites did not reduce.[@bib81]*Pistacia khinjuk*Alcoholic*L. tropica (MHOM/IR/2002/Mash2) & L. major (MRHO/IR/75/ER)*FruitsMice (Balb/c)NRIn vivo = after 30 days of treatment, 75 and 87.5% recovery were observed in the infected mice treated with 30% extract and meglumine antimoniate, respectively, while *P. khinjuk* extract at the concentration of 20% recovered 50% of the infected mice.[@bib82]*C. spinosa*Methanolic*L. major MRHO/IR/75/ER*RootMice (Balb/c)0.1,0.3,0.5,0.7,0.9 mg/mL for 24, 48 and 72 hIt was determined that 700 μg/ml and 900 g/ml *Caparis* root extract concentrations were more effective than other concentrations on amastigotes of *Leishmania* in ulcers. The results were sμggestive that *Caparis* root extract had significantly similar effect in reduction of ulcer size as compared to Glucantim[@bib55]*Matricaria chamomilla*Hydro alcoholic*L. major*FlowerMice (Balb/c)--The comparison of these three groups revealed that wound healing in group one and group two were 58.3% and 80% respectively, which was significant whereas no healing was seen in the control group[@bib83]*A. absinthium*Methanolic*L. major (MROH/IR/75/IR)*LeavesMice (Balb/c)daily for 30 days repeated 3 times*A. absinthium* extract was statistically significant\
The lesion size in different groups mice after 30 day = 9.9 ± 2.4 μg/mL[@bib58]*Vitex agnuscastus*Ethanolic*L. major (MROH/IR/75/IR)*LeavesMice (Balb/c)daily for 30 days repeated 3 timesThe lesion size in different groups mice after 30 day = 13.1 ± 2.8 μg/mL*Phytolaca americana*Methanolic*L. major (MROH/IR/75/IR)*FruitsMice (Balb/c)daily for 30 days repeated 3 timesThe lesion size in different groups mice after 30 day = 15.3 ± 2.6 μg/mL[^6]Table 3Results of subgroup meta-analysis for the mean of IC50 separately characteristics.Table 3CharacteristicsnIC5095% CII-squaredPLowerUpperStem barkAerial parts44553.10470.09636.11100.00%P\<0.001Root limb8123.4323.18247.0798.7%Bulbs322.834.0041.66100%Leaves or twigs3422.36393.00451.7299.8%PreparationEthanol9251.33137.64365.0389.32%P\<0.001Ethyl acetate11448.00337.96558.0497.01%Dichloromethane10531.82457.96605.68100.00%Hexane11910.92781.921039.9399.30%Methanolic359.7516.12103.3893.28%Aqueous423.895.8841.9089.36%Chloroformic3132.9012.99252.81100.00%Hydroalcoholic3510.00490.77529.23100.00%Botanic nameArtemisia spp498.07.48.697.1%P\<0.001Allium spp414.213.714.699.7%Alkanna spp69.48.310.698.5[^7]

4. Discussion {#sec4}
=============

Leishmaniasis is an important parasitic disease all around the world. For reducing the resistance in endemic areas, alternative strategies including the use of herbal plants are considered [@bib84], [@bib85]. The present study showed a wide range of plant extracts with antileishmanial properties in vitro and in vivo experiments. Among all medicinal plants, the genus *Artemisia* (Astraceae) is a large, heterogeneous, and widely dispersed genus all over the world. These species are small shrubs biennial and perennial or annual herbs. The genus *Artemisia* has 30 species in Iran out of which two are endemic [@bib86]. *Artemisia* plants contain chemical components such as sesquiterpenes, monoterpenes lactones, flavonoides, coumarins, sterols and polyacetylenes [@bib86]. *Artemisis species* has cytotoxic and anti-inflammatory activity [@bib86], [@bib87], [@bib88]. The results of a study carried out by Niloofarzadeh et al. (2008), showed that hydroalcoholic extracts of propolis *Thymus vulgaris* and *Achillea millefolium* were significantly more effective than systemic glucantime or alcoholic extract for the treatment of dermal leishmaniasis in Balb/c mice. The highest efficacy was observed for propolis, followed by *Achillea millefolium* and then *Thymus vulgaris* [@bib65]. The efficacy of ethanol extract of the root leaves and stem of *Berberis vulgaris* were topically used on experimental dermal lesions of Balb/c mice. The result after two weeks statistically revealed a significant reduction of ulcer size in mice [@bib89]. Doroodgar et al. (2008) reported the effect of various concentrations of *Artemisia* essence in Balb/c mice. They showed that cutaneous lesions in mice inoculated by *L. major* were enlarged after the application of higher concentration of the *Artemisia* essence. As a result, the lesions did not heal, and their size increased. In addition, parasitologic examination also remained positive [@bib67]. The result showed that the size of lesion in mice received 40, 60, and 80% of *Rubia. tinctorum* extracts revealed no significant difference in comparison with the lesion size in control group [@bib66]. *Seidlitzia rosmarinus (S. rosmarinus)* has been traditionally used in Mashhad and its suburbs for the treatment of CL. Despite little available data about the possible efficacy of this plant against leishmaniasis, the efficacy of herbal extracts of *S. rosmarinus* against cutaneous leishmaniasis in Balb/c mice was examined in this study. The natives in Khorasan Province used pure dried leaves\' powder of *S rosmarinus* leaves on their cutaneous lesions. Therefore, alcoholic extract of stem and leaves, which is almost similar to the pure powder, was used in this study. In this study, Eucerine was used as a base for the extracts; however, the results could be different if the researcher used vaseline or lanoline as a base for transdermal delivery of herbal extract [@bib61]. The ulcer size in Balb/c mice received Eucerine alone was significantly increased more than other groups which approved the previous suggestion.

The administration form of a drug is also important. In the present study, the extracts were topically used as an ointment, but the results would be different if the extracts were administered intralesionaly. Recent studies have shown that nanoparticles of anti-leishmanial drugs are highly effective to treat CL. The important advantages of such drugs are low dosage and minimum adverse reactions [@bib90].

In the present systematic review and meta-analysis, the Begg\'s test showed no publication bias among all studies (t = 1.25, p = 0.215). In addition, subgroup analysis revealed that there was a significant difference in extracting preparation including hexane, dichloromethane, hydroalcoholic and ethyl acetate with higher IC50 values, and aqueous or methanolic with lower IC50 values. (p \< 0.001) ([Table 3](#tbl3){ref-type="table"}).

However, several studies have demonstrated that the hexane and ether acetate extracts present low or no toxicity to host cells at the effective concentrations [@bib91], [@bib92]. Ribeiro et al. (2014) evaluated anti-leishmania activity of 44 extracts and fractions derived from 16 Brazilian plant species against *L. amazonensis*. Among them, the most potent extracts were the hexanic extract [@bib92].

In general, the ethanolic extracts were less effective and more toxic than the hexanoic extracts and buthanolic, dichloromethane ethyl acetate and hexanic fractions in the mammalian cells [@bib93]. Thus, the application of the hexanic extract against *Leishmania* parasites as a potent fraction is recommended in the in vivo experiments.

In the study of Hooshyar et al. (2014), a significant decrease was shown in the main lesion size, or the small lesions were not completely disappeared after treatment by *Hedera* helix (*H.helix*) alcoholic extract. Their results disagreed with those of Talari et al. who used, 100 and 50 mg/mL of *H. helix* extract and observed that all promastigotes of *L. major* were killed in vitro [@bib94]. This difference of findings may be due to different preparation methods and concentration of the plant extract was used in two studies. Different extract was gathered from eleven Iranian *Artemisia* species. Their leishmanicidal activities against the growth of *L. major* showed that ethanol extracts especially those taken from *A. ciniformis, A. santolina* and *A. kulbadica* had the strongest effects [@bib86]. In the present study, they demonstrated the inhibitory effect of different extracts from eleven *Artemisia* species on the growth of *L. major* promastigotes in vitro. It was previously reported that the aqueous extract and essential oil of *A. herbaalba* had antileishmanial activity against *L. tropica* and *L. major* promastigotes [@bib37]. In addition, the aqueous extract of leaves of *A. indica* exhibited leishmanicidal activity (IC50 = 430 μg/mL) [@bib95]. Here, some of tested *Artemisia* spp showed most strong antileishmanial activities. In this study, all tested extracts exhibited antileishmanial activity after incubation, however, ethanol extracts from *A. ulbadica* and *A. ciniformis* showed the stronger leishmanicidal activity at value of (IC50 = 25 μg/mL). Growth inhibitory effect of ethanol extract of other plants such as *Haplo phylum myrtifolium* against *L. tropica* promastigotes were previously reported (IC50 = 10.9 μg/mL) [@bib96]. Comparing the antileishmanial effect of non-polar extracts revealed that ethyl acetate extract of *A. fragrans* had less antileishmanial activity against *L. major* promastigotes. Ethyl acetate extracts of studied *Artemisia* species (except for *A. turanica* and *A. fragrans*) were also more active in comparison with their dichloromethane extract. In vitro antileishmanial activity of ethyl acetate and dichloromethane extracts of *Ircinia spinosula* (IC50 = 16.09, 47.38 μg/mL) were reported against *L. major* promastigotes [@bib97]. The lethal dose (LD50) of dichloromethane extract and hexane extract of *Calophyllum brasiliense* on *L. amazonensis* promastigotes were 40 mg/mL and 20 mg/mL, respectively [@bib98]. In comparison with other extracts, *Artemisia* studying species hexane extracts (except for *A. fragrans*) were less active than *L. major*. Hexane extracts of *A. biennis, A. annua, A. turanica, A. fragrans* and *A. absinthium* were less effective than other species. Other investigators have also reported lower activity of hexane extracts of plants than *Leishmania* species in comparison with other extracts. For example, ethanol extracts of *Arbutus unedo* significantly decreased *L. tropica* promastigotes counts [@bib99].

Leishmanicidal activity of *Allium sativum* (garlic extract) has been established against infection with *L. major*, so that it can induce a Th1-type response, stimulate INF-γ and NO production in macrophage and thus prevent the progression of the infection [@bib73], [@bib28]. To improve the therapeutic efficacy and reduce toxicity, above mentioned natural molecules can be applied as either scaffold for producing and exploring new immune drugs or natural immunomodulators in synergy and in combination with existing drugs [@bib100], [@bib101]. Targeting anti-leishmanial drugs to macrophages with drug delivery systems reflects a hopeful strategy overcoming the problems associated with the current treatment protocols.

Another important issue is the safety of natural remedies. Although natural immune therapy in different generations has been tested and approved, it is necessary to prove the overall pharmacological safety of the correction. Chemical agents in Iranian drug market have disadvantages such as high cost and side effects. Considering the effectiveness of these plants would make them as a source of natural and safe agents for the treatment of leishmaniasis. However, anti -leishmanial drugs or natural compounds are safe when their selectivity index is more than 10 [@bib50].

5. Conclusion {#sec5}
=============

In conclusion, the present review showed that a range of plant extracts had effects on promastigote stage of *Leishmania* and interesting antileishmanial properties exhibited in vitro and in vivo. Therefore, it might be possible to use the extracts instead of chemical drugs. However, almost all of the authors claimed successful results about their investigated plants, but their studies really had limitations which affected with the accuracy of their results. Some of defects included in these studies are described in detail as lacking of randomized double blind clinical trials in all of human based studies. Also some of investigations were performed in vitro and were not performed in vivo [@bib102], [@bib103]. The period of exposure of extracts was not enough in some of the studies [@bib104] and at last in one study, the toxicity level of the plant investigated was very high for testing in volunteer patients [@bib105]. Most of data published were obtained from animal model and were not tested on human [@bib106]. According to all documented data, phytotherapy has provided a large and hopeful vision to new, safe, and effective leishmaniacidal agents. Nevertheless, it needs to generalize all results obtained from in vitro and in vivo studies on the efficacy of plant extracts, metabolites or formulations against different *Leishmania* species to validate their activities. We concluded that the mechanism of action was enhancing the hosts\' cellular immunity.

The present systematic investigation on anti-leishmanial activity of the medicinal plants together with their toxicity, mechanism of action and chemical properties for improvement is the most favorable formulation urgently required to confirm their efficacy in the treatment of leishmaniasis.

As a whole, the present systematic review provide valuable information about the natural products with anti -leishmanial activity which would be very favorable for experimental and clinical trials and herbal combination therapy studies. Consequently, further clinical researches are needed to establish the effective and safe medicinal plants therapy. It is necessary to find their active components, and potential toxic effects would lead to producing the well-tolerated and safe drugs for leishmaniasis.
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[^1]: IC50: concentration of drμg that causes 50% growth inhibition of amastigote or promastigote forms of *Leishmania*.

[^2]: IC100: concentration of drμg that causes 100% growth inhibition of amastigote or promastigote forms of Leishmania.

[^3]: CC50: as the Cytotoxic concentration of the extracts to cause death to 50% of viable cells in the host.

[^4]: LD50: (Lethal Dose, 50%) It is the amount of the substance required (usually per body weight) to kill 50% of the test population.

[^5]: NR: Not reported.

[^6]: Mixture of Althaea rosa, Althaea officinalis, and Pharmacology, Pathology, and members of the families Leguminosae, Faliaceae, Malvaceae, and Lythraceae.

[^7]: n: sample size.
